SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending as the community eagerly discusses the onset of a new year, with many anticipating a significant shift after what some perceive as a challenging period. Conversations frequently highlight expectations for a potential bullish breakout, contrasting with cautionary views from those who believe further downside is possible. The debate centers on whether LTC, often dubbed "digital silver," is poised for substantial growth in the upcoming market cycle.

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

Intelligent Bio Solutions is currently trending after announcing a strategic manufacturing partnership to scale production of its fingerprinting drug screening reader, anticipating significant cost savings and margin improvements ahead of its U.S. market entry. The community is buzzing with speculative interest, comparing it to other low-float runners and actively discussing its potential for substantial further gains amid intense trading volatility.

Sensei Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company was founded in 1999 and is headquartered in Rockville, MD.

Sensei Biotherapeutics Inc

Sensei Biotherapeutics (SNSE) is a top trending stock, with intense community discussion centered on its extremely low float and strong potential for a short squeeze. Many traders are actively accumulating shares, comparing it to recent parabolic runners and speculating on a multi-day breakout, especially as the company explores strategic alternatives.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is trending due to the recently completed Ask Sage acquisition, a strategic move many believe enhances its secure generative AI capabilities for defense. However, the repeated postponement of a critical proxy vote is fueling investor uncertainty and spirited debate regarding potential future share dilution. The community remains sharply divided between those anticipating significant government AI contracts and others concerned about immediate operational execution and leadership.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood is trending as recent analyst concerns about crypto trading volumes dampen sentiment, fueling a sharp divide among investors. While many express frustration over persistent price declines and perceived underwhelming holiday giveaways, long-term bulls view current dips as an opportunity, citing the platform's expansion into new markets like predictions. The broader conversation frequently links its performance to the cryptocurrency market and year-end market dynamics.

ESH Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on November 17, 2021 and is headquartered in New York, NY.

ESH Acquisition Corp - Ordinary Shares - Class A

ESH Acquisition Corp ($ESHA) is trending with high volatility, fueled by its low-float SPAC structure and significant insider ownership, which is attracting speculative trading interest. The community is actively discussing its potential for a substantial short squeeze or parabolic run, with many investors encouraging holding shares to capitalize on perceived explosive movements, despite its highly speculative nature.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics (CORT) is trending following a substantial stock drop after the FDA issued a Complete Response Letter for its relacorilant drug, citing the need for more efficacy evidence in Cushing's syndrome. The community is sharply divided, with many investors calling the sell-off an overreaction given the company's strong existing revenue from Korlym and diverse pipeline, prompting some to buy the dip. However, others remain cautious, highlighting the regulatory setback and concerns about potential information leaks to institutions before the public announcement.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending following FDA approval for NEREUS, a significant milestone as the first new motion sickness treatment in over four decades. The community is buzzing with expectations for substantial upside, largely driven by the drug's potential to address GLP-1 associated nausea and positioning VNDA as a prime acquisition target for larger pharma. With additional pipeline catalysts approaching, traders anticipate continued long-term value creation for the company.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is trending following recent regulatory updates, including the FDA's priority review for its AXS-05 Alzheimer's disease agitation treatment and progress towards an NDA submission for AXS-12 in narcolepsy. The community is highly optimistic about these developments and continued strong sales of Auvelity, viewing the company as a future leader in CNS therapeutics with significant pipeline potential. This confluence of catalysts has fueled substantial investor enthusiasm, driving the stock to new highs.

Sable Offshore Corp. engages in offshore oil and gas field operations. It focuses on developing the prolific Santa Ynez Unit in federal waters offshore California. The company was founded by James C. Flores on October 16, 2020 and is headquartered in Houston, TX.

Sable Offshore Corp.

Sable Offshore Corp. is trending due to the U.S. Department of Transportation's PHMSA approving an emergency special permit to restart critical segments of its Santa Ynez Pipeline System, a move widely seen as bypassing California's state regulatory opposition. This federal backing, viewed by bulls as a "game-changer" for unlocking stored oil and achieving energy independence, has ignited strong bullish sentiment, anticipating significant price appreciation. However, skeptics caution that the company still faces an "uphill legal battle" from environmental groups, raising concerns about potential pump-and-dump scenarios and ongoing financial hurdles despite the recent regulatory win.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


MBLAC
MobileAccess

Latest MBLAC News

MBLACMobileAccess

Latest MBLAC News

MBLAC
MobileAccess